A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans
Arome Solomon Odiba,Olanrewaju Ayodeji Durojaye,Ifeoma Maureen Ezeonu,Anthony Christian Mgbeahuruike,Bennett Chima Nwanguma
DOI: https://doi.org/10.2147/IDR.S360973
2022-06-17
Infection and Drug Resistance
Abstract:Arome Solomon Odiba, 1, 2 Olanrewaju Ayodeji Durojaye, 3– 5 Ifeoma Maureen Ezeonu, 6 Anthony Christian Mgbeahuruike, 7 Bennett Chima Nwanguma 1, 2 1 Department of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria; 2 Department of Molecular Genetics and Biotechnology, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria; 3 Department of Chemical Sciences, Coal City University, Emene, Enugu State, Nigeria; 4 Department of Molecular and Cell Biology, University of Science and Technology of China, Hefei, Anhui, 230026, People's Republic of China; 5 MOE Key Laboratory of Membraneless Organelle and Cellular Dynamics, Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei, Anhui, People's Republic of China; 6 Department of Microbiology, Faculty of Biological Sciences, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria; 7 Department of Veterinary Pathology and Microbiology, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria Correspondence: Bennett Chima Nwanguma; Anthony Christian Mgbeahuruike, Department of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Enugu State, Nsukka, 410001, Nigeria, Tel +234 8063655062, Email ; Background: Resistance to antifungal drugs for treating Candida infections remains a major concern globally despite the range of medications available. Most of these drugs target key proteins essential to the life cycle of the organism. An enzyme essential for fungal cell membrane integrity, lanosterol 14–α demethylase (CYP51), is encoded by the ERG11 gene in Candida species. This enzyme is the target of azole–based drugs. The organism has, however, devised molecular adaptations to evade the activity of these drugs. Materials and Methods: Classical methods were employed to characterize clinical isolates sampled from women and dogs of reproductive age. For fluconazole efficacy studies, CLSI guidelines on drug susceptibility testing were used. To understand the susceptibility pattern, various molecular and structural analytic approaches, including sequencing, in silico site-directed mutagenesis, and protein-ligand profiling, were applied to the ERG11 gene and CYP51 protein sequences. Several platforms, comprising Clustal Omega, Pymol plugin manager, Pymol molecular visualizer, Chimera–curated Dynameomics rotamer library, protein–ligand interaction profiler, Charmm36 force field, GROMACS, Geneious, and Mega7, were employed for this analysis. Results: The following Candida species distribution was obtained: 37.84% C. albicans , 8.12% C. glabrata , 10.81% C. krusei , 5.41% C. tropicalis , and 37.84% of other unidentified Candida species. Two codons in the nucleotide sequence of the wild-type (CTC and CCA) coding for LEU– 370 and PRO– 375, respectively, were mutated to L370S and P375H in the resistant strain. The mutation stabilized the protein at the expense of the heme moiety. We found that the susceptible isolate from dogs ( Can–iso– 029/dog ) is closely related to the most resistant isolate from humans. Conclusion: Taken together, our results showed new mutations in the heme-binding pocket of caCYP51 that explain the resistance to fluconazole exhibited by the Candida isolates. So far, the L370S and P375H resistance-linked mutations have not been previously reported. Keywords: Candida infection, CYP51, drug resistance, ERG11 , fluconazole, mutation Most vaginal infections are very uncomfortable, with symptoms that include itching, pain during sexual intercourse, and soreness in the vagina. Vulvovaginal candidiasis is one such infection in which a serious condition could lead to vaginal cracks. This infection is caused by different species of the microorganism known as Candida , of which the most common is Candida albicans . Several drugs, including fluconazole, have been developed to effectively treat this infection. However, these drugs are not effective in treating some cases because some isolates of this organism have developed a mechanism called mutations that enables them to become resistant to the drugs. Understanding the cause of this resistance will help health professionals combat this challenge. Hence, many researchers have studied many causes of this resistance but have not sufficiently understood all possibilities. In this study, we used a variety of proven methods to discover a new cause of fluconazole resistance by Candida foun -Abstract Truncated-
pharmacology & pharmacy,infectious diseases